Abstract
The so-called “hub proteins” are those proteins in a protein-protein interaction network system that have remarkably higher interaction relations (or degrees) than the others. Therefore, the information of hub proteins can provide very useful insights for selecting or prioritizing targets during drug development. In this paper, by combining the multiagent- based method with the graphical spectrum analysis and immune-genetic algorithm, a novel simulator for identifying the hub proteins from membrane protein interaction networks is proposed. As a demonstration of using the simulator, two hub membrane proteins, YPL227C and YIL147C, were identified from a complicated network system consisting of 1500 membrane proteins. Meanwhile, along with the two identified hub proteins, their molecular functions, biological processes, and cellular components were also revealed. It is anticipated that the hub-protein-simulator may become a very useful tool for system biology and drug development, particularly in deciphering unknown protein functions, determining protein complexes, and in identifying the key targets from a complicated disease system.
Keywords: Hub protein, membrane protein interaction network, dynamic performance, collective operation, graphic approach, spectrum analysis, immune-genetic algorithm, multi-agent systems
Medicinal Chemistry
Title: Identifying the Hub Proteins from Complicated Membrane Protein Network Systems
Volume: 6 Issue: 3
Author(s): Yi-Zhen Shen, Yong-Sheng Ding, Quan Gu and Kuo-Chen Chou
Affiliation:
Keywords: Hub protein, membrane protein interaction network, dynamic performance, collective operation, graphic approach, spectrum analysis, immune-genetic algorithm, multi-agent systems
Abstract: The so-called “hub proteins” are those proteins in a protein-protein interaction network system that have remarkably higher interaction relations (or degrees) than the others. Therefore, the information of hub proteins can provide very useful insights for selecting or prioritizing targets during drug development. In this paper, by combining the multiagent- based method with the graphical spectrum analysis and immune-genetic algorithm, a novel simulator for identifying the hub proteins from membrane protein interaction networks is proposed. As a demonstration of using the simulator, two hub membrane proteins, YPL227C and YIL147C, were identified from a complicated network system consisting of 1500 membrane proteins. Meanwhile, along with the two identified hub proteins, their molecular functions, biological processes, and cellular components were also revealed. It is anticipated that the hub-protein-simulator may become a very useful tool for system biology and drug development, particularly in deciphering unknown protein functions, determining protein complexes, and in identifying the key targets from a complicated disease system.
Export Options
About this article
Cite this article as:
Shen Yi-Zhen, Ding Yong-Sheng, Gu Quan and Chou Kuo-Chen, Identifying the Hub Proteins from Complicated Membrane Protein Network Systems, Medicinal Chemistry 2010; 6 (3) . https://dx.doi.org/10.2174/1573406411006030165
DOI https://dx.doi.org/10.2174/1573406411006030165 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
Call for Papers in Thematic Issues
Carbohydrates in Computational and Medicinal Chemistry
Carbohydrates are the most essential organic molecules and are involved in the maintenance of various physiological and metabolic processes in living organisms. Carbohydrate-based compounds have come to the attention of researchers because of their significant contributions to biological functions, such as cell development and cell proliferation, connections between several cells, ...read more
Recent Advances in the Medicinal Chemistry of Cancer
Scope of the Thematic Issue: Correlation between structure and function is one of the important aspects of the success of anti-cancer compounds associated with their structure-activity interactions, physiology, biochemical, molecular, and genetic processes. Overcoming these obstacles is key to obtaining further insights into developments in rational drug design, bioorganic chemistry, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Anti-Thrombotic Drugs for Stroke Prevention
Current Vascular Pharmacology CB1 Cannabinoid Antagonists: Structure-Activity Relationships and Potential Therapeutic Applications
Current Topics in Medicinal Chemistry Recent Advances in the Development of MMPIs and APNIs Based on the Pyrrolidine Platforms
Mini-Reviews in Medicinal Chemistry A Generic Computer-Assisted Four-Pronged Approach for the Management of Emerging Global Pathogens: Some Comments on COVID-19
Current Computer-Aided Drug Design From Na+/K+-ATPase and Cardiac Glycosides to Cytotoxicity and Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Molecular Topology and Other Promiscuity Determinants as Predictors of Therapeutic Class - A Theoretical Framework to Guide Drug Repositioning?
Current Topics in Medicinal Chemistry Albumin Infusion Therapy in Stroke, Sepsis and the Critically Ill
Current Nutrition & Food Science Vaccination and Antiviral Treatment of Neglected Diseases Caused by Flaviviral Infections
Current Medicinal Chemistry First Discovery of Tylophora Alkaloids as HIV Inhibitors
Letters in Drug Design & Discovery Third Wave of the COVID-19 Pandemic: Prominence of Initial Public Health Interference
Infectious Disorders - Drug Targets The HIV Pandemic: A Forgotten Crisis?
Current Drug Targets - Infectious Disorders An Insight into Pyrazole-containing Compounds: Synthesis and Pharmacological Activities
Anti-Infective Agents Clinical and <i>In Silico</i> Outcomes of the Expression of miR-130a-5p and miR-615-3p in Tumor Compared with Non-Tumor Adjacent Tissues of Patients with BC
Anti-Cancer Agents in Medicinal Chemistry Antiandrogens in Prostate Cancer Endocrine Therapy
Current Cancer Drug Targets An Overview of Biotechnological Applications in Ayurveda: Amalgamation of Modern Techniques and Science
Current Traditional Medicine Benzimidazole-derived Compounds Designed for Different Targets of Alzheimer’s Disease
Current Medicinal Chemistry Virtual Screening and Molecular Docking: Discovering Novel c-KIT Inhibitors
Current Medicinal Chemistry Advancements in Non-steroidal Antiandrogens as Potential Therapeutic Agents for the Treatment of Prostate Cancer
Mini-Reviews in Medicinal Chemistry Immunological Targets in Inflammation from the Small Molecule Perspective
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Plant MicroRNA Potential in Targeting Sars-CoV-2 Genome Offering Efficient Antiviral MiRNA-Based Therapies
MicroRNA